Literature DB >> 21795044

Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors.

Reşit Çakmak1, Serdar Durdagi, Deniz Ekinci, Murat Sentürk, Giray Topal.   

Abstract

Discovery of GR inhibitors has become very popular recently due to antimalarial and anticancer activities. In this study, the synthesis and GR inhibitory capacities of novel nitroaromatic compounds (NCs) (1-3) were reported. Some commercially available molecules were also tested for comparison reasons. The novel NCs were obtained in high yields using simple chemical procedures and exhibited much potent inhibitory activities against GR at low micromolar concentrations with K(i) values ranging from 0.211 to 4.57 μM as compared with well-known agents. Inhibition mechanism was assessed as being due to occlusion of the active site entrance by means of the NCs. Molecular docking results have shown that docking poses of ligands are able to construct binding interactions with the essential amino acids.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795044     DOI: 10.1016/j.bmcl.2011.07.002

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Azoreductases in drug metabolism.

Authors:  Ali Ryan
Journal:  Br J Pharmacol       Date:  2016-09-02       Impact factor: 8.739

2.  Determination of the inhibitory effects of N-methylpyrrole derivatives on glutathione reductase enzyme.

Authors:  Esma Kocaoğlu; Oktay Talaz; Hüseyin Çavdar; Murat Şentürk; Claudiu T Supuran; Deniz Ekinci
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

3.  Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on Plasmodium falciparum Glutathione Reductase.

Authors:  Audronė Marozienė; Mindaugas Lesanavičius; Elisabeth Davioud-Charvet; Alessandro Aliverti; Philippe Grellier; Jonas Šarlauskas; Narimantas Čėnas
Journal:  Molecules       Date:  2019-12-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.